摘要
Hydroxychloroquine(HCQ)是近50年来作为一个最迷人的合成抗疟药物。它是目前最常用的药物为临床治疗中风湿性疾病的治疗,尤其是系统性红斑狼疮和类风湿性关节炎。在相关机制的研究,人们已经发现,羟氯喹具有多种免疫调节和抗炎炎症活动。此外,HCQ抗血小板的作用,代谢途径,并antineoplasticity也已在最近的研究揭示了。这些重要的发现对HCQ萨格EST治疗许多疾病有关的潜在的治疗应用,如癌症、皮肤病、抗磷脂综合征,等审查的重点是最近在体外和临床试验ALS的药理机制、治疗活性及潜在的不良反应。
关键词: 免疫调节活性,羟氯喹,系统性红斑狼疮,类风湿性关节炎、风湿性疾病。
Current Medicinal Chemistry
Title:The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases
Volume: 24 Issue: 20
关键词: 免疫调节活性,羟氯喹,系统性红斑狼疮,类风湿性关节炎、风湿性疾病。
摘要: Hydroxychloroquine (HCQ) is known as one of the most fascinating synthetic antimalarial drugs during the last 50 years. It is currently among the most commonly employed medicines for the clinical treatment of rheumatic diseases, especially systemic lupus erythematosus and rheumatoid arthritis. In related mechanism studies, it has been found that HCQ possesses various immunomodulatory and anti-inflammatory activities. In addition, the effects of HCQ on anti-platelet, metabolic pathways, and antineoplasticity have also been disclosed in more recent studies. These significant findings on HCQ suggest the potential therapeutic applications of HCQ for treatment of many diseases, such as cancers, skin disease, antiphospholipid syndrome, etc. This review focuses on recent in vitro and clinical trials on its pharmacological mechanisms, therapeutic activities, and potential adverse effects.
Export Options
About this article
Cite this article as:
The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases, Current Medicinal Chemistry 2017; 24 (20) . https://dx.doi.org/10.2174/0929867324666170316115938
DOI https://dx.doi.org/10.2174/0929867324666170316115938 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Anti-Inflammatory Role of Annexin-1 in Arthritis
Current Rheumatology Reviews Recent Developments of p38α MAP Kinase Inhibitors as Antiinflammatory Agents Based on the Imidazole Scaffolds
Current Medicinal Chemistry Role of PGE2 and EP Receptors in the Pathogenesis of Rheumatoid Arthritis and as a Novel Therapeutic Strategy
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-TNFs for Postoperative Recurrence in Crohns Disease: The Ifs and Hows
Current Drug Targets P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke
Current Neuropharmacology Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and / or High Dose Chemotherapy with Hematopoietic Stem Cell Support
Current Pharmaceutical Design Bacterial Conjunctivitis in Childhood: Etiology, Clinical Manifestations, Diagnosis, and Management
Recent Patents on Inflammation & Allergy Drug Discovery Biologics for Extraintestinal Manifestations of IBD
Current Drug Targets Body Mass Index Impact on Disease Activity, Clinical and Sonographic Remission Rates in Patients with Rheumatoid Arthritis
Current Rheumatology Reviews Role of Inflammatory Mediators in Angiogenesis
Current Drug Targets - Inflammation & Allergy Preface:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cytokine Targeting in Osteoarthritis
Current Drug Targets Early Vascular Aging: A New Target for Hypertension Treatment
Current Pharmaceutical Design n-Butyl-α-D-fructofuranoside Isolated from Ulmus davidiana Enhances Nrf2 Activity Through Activation of JNK
Current Pharmaceutical Biotechnology The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma
Current Cancer Drug Targets The GABAergic System and the Gastrointestinal Physiopathology
Current Pharmaceutical Design Editorial [Hot Topic: Pain - Unmet Need and Emerging Targets & Therapies (Guest Editor: Sivaram Pillarisetti)]
CNS & Neurological Disorders - Drug Targets Adenosine Receptors: What We Know and What We are Learning
Current Topics in Medicinal Chemistry COX-2 Inhibitors Celecoxib and Parecoxib: Valuable Options for Postoperative Pain Management
Current Topics in Medicinal Chemistry